The Department would like to announce that we are currently accepting Curriculum Vitae submissions for potential Pharmacy and Therapeutics Committee members.   

Please click here to obtain information on how to apply to serve on this committee. 

Background

The Pharmacy and Therapeutics (P&T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).

The P&T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations.  The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.

The P&T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director.  Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.

Presenting testimony

Interested parties that would like to present testimony to the P&T Committee may sign up on the day of a meeting; however, the Department encourages giving advanced notice by contacting Jim Leonard, the committee coordinator, at 303-866-3502 or Jim.Leonard@state.co.us 

P&T Committee Next Meeting

Tuesday  January 12, 2010

1:00pm - 5:00pm

225 E. 16th Ave, 1st Floor Conference Room

Denver, CO

P&T Committee Meeting Minutes